Optimizing Intensive Chemotherapy Management in Secondary AML Through Academic Community Collaboration - Episode 4
Patient-Centered Decision-Making in Secondary AML Treatment
Panelists discuss how involving patients and caregivers in the treatment decision-making process for secondary acute myeloid leukemia (AML) requires clear communication, education about options, and consideration of individual values and preferences to ensure informed and shared decision-making.
Video Player is loading.
Video content above is prompted by the following:
- How do you involve the patient and their caregivers in the decision-making process when determining the appropriate treatment?
Related Content:
